EQUIMUNE®
EQUIMUNE®
An immunotherapeutic for the treatment of Equine Respiratory Disease Complex.
Description:
Equimune ® is an emulsion of purified Mycobacterium cell walls which have been extracted by a chemical process that insures complete inactivation.
Equimune is a USDA-approved immunotherapeutic for the treatment of Equine Respiratory Disease Complex (ERDC) of viral origin.
The common causes of ERDC are equine herpesvirus (rhinopneumonitis), influenza A
equine-1 (H7N7) and influenza A equine-2 (H3N8).
Equimune helps to:
- Minimize lung damage
- Stimulate the healing process
- Rapidly return the equine athlete to normal Studies have shown that a single dose of Equimune generates a non-specific amplification of the immune response to antigens. The product is safe to use in pregnant mares.
Optimum treatment timing is at the onset of disease during the early acute period. Treatment at this time boosts the early immune response, allowing less time for the invading organism to become established and cause significant cellular damage.
1 vial single dose per animal
Equimune I.V. is available in single-dose vials.
The brief description of the medicine is for information purpose only. Read the content of the package leaflet carefully before use. If you have any further questions, ask your veterinarian or pharmacist.